A detailed history of Sherbrooke Park Advisers LLC transactions in Outset Medical, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 16,026 shares of OM stock, worth $18,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,026
Holding current value
$18,109
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.45 - $4.82 $7,211 - $77,245
16,026 New
16,026 $10.9 Million
Q4 2023

Feb 14, 2024

BUY
$3.07 - $10.25 $43,029 - $143,664
14,016 New
14,016 $75.8 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $54.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.